CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH METASTATIC KRAS-MUTANT LUNG ADENOCARCINOMAS.
Mutations in the KRAS gene are the most common driver oncogenes present in lung adenocarcinomas. We analyzed the largest multi-institutional database available containing patients with metastatic KRAS mutant lung adenocarcinomas. In the LCMC study, 27% of lung adenocarcinomas patients harbored a KRAS mutation and up to third of them had another oncogenic driver. Patients with […]
